IGF-1

The Food and Drug Administration has not evaluated these statements. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition. For laboratory research use only. Not for human consumption.

IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) is a synthetic analog of insulin-like growth factor-1 that has been modified to improve stability and reduce binding to insulin-like growth factor binding proteins (IGFBPs), resulting in an extended duration of activity compared to native IGF-1.

The LR3 modification consists of a substitution at the third amino acid position and the addition of a 13-amino acid extension at the N-terminus. These structural changes make IGF-1 LR3 a valuable research tool for investigating receptor interactions, cellular signaling pathways, pharmacokinetics, and peptide stability under controlled laboratory conditions.

Research models utilize IGF-1 LR3 to study IGF-1 receptor activation, intracellular signaling mechanisms, and the effects of prolonged peptide exposure on biological systems. Its extended activity allows researchers to compare sustained receptor engagement and systemic distribution with that of native IGF-1 and other related growth factor analogs.

This product is manufactured for research purposes only and is intended exclusively for qualified laboratory professionals conducting scientific investigations.